Development of a brain permeable microtubule-targeting agent to treat glioblastoma [ 2019 - ]

Research Grant

Researchers: A/Pr Lenka Munoz (Principal investigator) ,  Prof Michael Kassiou ,  Prof Terrance Johns

Brief description This project enables development of a new drug for patients with brain tumours. Our drug candidate is a unique microtubule-targeting agent with the ability to cross the blood-brain barrier, a cellular layer protecting the brain. Once inside the brain, it efficiently kills brain cancer cells. This is not the case with current cancer drugs. Further work is required to fully evaluate its therapeutic potential, thereby securing licencing agreement and clinical development by our commercial partner.

Funding Amount $555,754.00

Funding Scheme Development Grants

Notes Development Grant